This is BIG news. DS were to produce 2m units by end December and 4 by end march. So to date it looks like Laninamivir is a raging success. Important to see if this seasonal and hence recurring or stockpiling demand. The seasonal market received a "free" bout of advertising thanks to global media and swine flu.
If the number is correct this will bode very well indeed for the ROW program. Go BTA!!
